Brief: Karyopharm Therapeutics: Selling Stockholder May Resell Up To 8,843,036 Shares Of Karyopharm Common Stock - SEC Filing
04/05/2026 21:42
May 4 (Reuters) - Karyopharm Therapeutics Inc KPTI.O: KARYOPHARM THERAPEUTICS INC - SELLING STOCKHOLDER MAY RESELL UP TO 8,843,036 SHARES OF KARYOPHARM COMMON STOCK - SEC FILING Source text: [ID:n0001193125-26-204134] Further company coverage: KPTI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karyopharm Therapeutics
See all newsBrief: Karyopharm Therapeutics - Enters Forbearance Agreement And Waiver On Sept 10, 2026 - SEC Filing
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Karyopharm Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into September
Karyopharm Therapeutics Inc. expected to post a loss of $1.28 a share - Earnings Preview